THC Electrochemical Sensors Must Address Matrix Interference as Well as Detection Sensitivity

A 2022 narrative review found promise in rapid electrochemical THC detection while identifying nonspecific interactions and matrix interference as major challenges. A low detection limit alone does not establish reliable performance in a real biological specimen.

The reviewed applications were diverse

The review considered synthetic samples, plant material and oral fluid. These are different analytical environments. A sensor that performs well in a prepared solution has not thereby demonstrated equivalent behavior in oral fluid containing other chemical constituents.

Sensitivity and selectivity answer different questions

Sensitivity concerns the response to the target under tested conditions. Selectivity concerns distinguishing that response from other influences. Improving one does not necessarily resolve the other, particularly when a surface coating can interact with compounds in the specimen.

Storage and reuse introduce additional demands

The review noted special storage needs for sensors modified with proteins or antibodies and identified durable, reusable sensors as a research priority. A strong initial response is not the same as stable performance over the device's intended working life.

Interpreting the evidence

A forensic technology assessment should retain the tested matrix, interference experiments and storage conditions beside the detection limit. This synthesis supports further analytical development. It does not establish that all promising prototypes are ready for roadside use or can measure impairment from a chemical signal.

Related reading: interpreting cannabis tolerance claims.

Research reference

Kaveh Amini; Ali Sepehrifard; Ali Valinasabpouri; Jennifer Safruk; Davide Angelone; Tiago de Campos Lourenco (2022). Recent advances in electrochemical sensor technologies for THC detection—a narrative review. Journal of Cannabis Research. doi:10.1186/s42238-022-00122-3.

This discussion draws on the abstract and introductory material in the supplied research synthesis.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us